Free Trial

Hamilton Lane Incorporated (NASDAQ:HLNE) Receives Consensus Recommendation of "Reduce" from Brokerages

Hamilton Lane logo with Finance background

Hamilton Lane Incorporated (NASDAQ:HLNE - Get Free Report) has been assigned a consensus recommendation of "Reduce" from the seven research firms that are presently covering the stock, MarketBeat.com reports. One research analyst has rated the stock with a sell recommendation and six have given a hold recommendation to the company. The average 12-month price objective among brokers that have issued ratings on the stock in the last year is $164.14.

HLNE has been the subject of a number of recent analyst reports. Wells Fargo & Company reduced their target price on Hamilton Lane from $152.00 to $147.00 and set an "equal weight" rating for the company in a report on Tuesday, April 8th. Oppenheimer lowered Hamilton Lane from an "outperform" rating to a "market perform" rating in a report on Thursday, May 15th. Morgan Stanley reduced their target price on Hamilton Lane from $190.00 to $157.00 and set an "equal weight" rating for the company in a report on Monday, April 14th. Keefe, Bruyette & Woods lifted their target price on Hamilton Lane from $158.00 to $168.00 and gave the company a "market perform" rating in a report on Wednesday, February 5th. Finally, JPMorgan Chase & Co. reduced their target price on Hamilton Lane from $176.00 to $167.00 and set a "neutral" rating for the company in a report on Tuesday, April 29th.

Read Our Latest Analysis on HLNE

Hamilton Lane Trading Down 0.1%

Shares of HLNE opened at $172.52 on Tuesday. The business has a 50-day moving average of $149.86 and a 200 day moving average of $159.54. Hamilton Lane has a fifty-two week low of $114.85 and a fifty-two week high of $203.72. The firm has a market cap of $9.56 billion, a P/E ratio of 31.83 and a beta of 1.31. The company has a debt-to-equity ratio of 0.34, a quick ratio of 4.19 and a current ratio of 4.19.

Hamilton Lane Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Friday, April 4th. Stockholders of record on Friday, March 14th were given a dividend of $0.49 per share. The ex-dividend date of this dividend was Friday, March 14th. This represents a $1.96 dividend on an annualized basis and a dividend yield of 1.14%. Hamilton Lane's dividend payout ratio (DPR) is presently 36.16%.

Institutional Trading of Hamilton Lane

A number of large investors have recently modified their holdings of HLNE. MassMutual Private Wealth & Trust FSB boosted its position in shares of Hamilton Lane by 252.0% during the 1st quarter. MassMutual Private Wealth & Trust FSB now owns 176 shares of the company's stock valued at $26,000 after acquiring an additional 126 shares during the last quarter. WPG Advisers LLC bought a new stake in shares of Hamilton Lane during the 1st quarter valued at about $26,000. Versant Capital Management Inc bought a new stake in shares of Hamilton Lane during the 1st quarter valued at about $30,000. Whittier Trust Co. of Nevada Inc. bought a new stake in shares of Hamilton Lane during the 1st quarter valued at about $33,000. Finally, CBIZ Investment Advisory Services LLC lifted its position in Hamilton Lane by 27.0% in the 4th quarter. CBIZ Investment Advisory Services LLC now owns 287 shares of the company's stock worth $43,000 after buying an additional 61 shares during the last quarter. Institutional investors own 97.40% of the company's stock.

About Hamilton Lane

(Get Free Report

Hamilton Lane Incorporated is a private equity firm specializing in early venture, emerging growth, turnaround, middle market, mature, mid-venture, bridge, buyout, distressed/vulture, loan, mezzanine in growth capital companies. It prefers to invest in energy, industrials, consumer discretionary, health care, real estate, information technology, utilities, and consumer services.

See Also

Analyst Recommendations for Hamilton Lane (NASDAQ:HLNE)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Hamilton Lane Right Now?

Before you consider Hamilton Lane, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Hamilton Lane wasn't on the list.

While Hamilton Lane currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Best High-Yield Dividend Stocks for 2025 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

This $13 Trillion Energy Breakthrough Will Make Millionaires
Magnificent 7 Stocks Shift Toward Stability and Selective Growth
4 Biotech Stocks on the Verge of Massive Breakthroughs

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines